Venture CapitalRIA · CRD 313397SEC-RegisteredPrivate Fund Adviser

Updated:

OMX Ventures

OMX Ventures is a venture capital based in Lincolnshire, founded 2020; the Altss profile covers its classification, headquarters, registration, AUM band, and...

OMX Ventures logo

OMX Ventures

OMX Ventures is an SEC-registered investment adviser based in Lincolnshire, IL, registered since 2021. It advises clients on investment strategies.

General information

Firm type

Venture Capital

Year founded

2020

AUM

Undisclosed

Location

Region

North America

Country

United States

City

Lincolnshire

Corporate office

One Overlook Point, Suite 100, Lincolnshire, IL 60069, United States

Sector focus

TherapeuticsBioTools & DiagnosticsSynthetic Bio

Frequently asked questions

How does OMX Ventures source and structure its biotech investments?

OMX operates as a technology-first builder VC, taking discoveries from academic or early-stage contexts and standing up scalable companies around them. Rather than participating in large syndicated rounds as a passive minority investor, the firm works to convert platform science into operational businesses, often with a transatlantic dimension linking US and European innovation.

Does OMX focus on specific therapeutic areas, or is it platform-agnostic?

The firm tags three core buckets — Therapeutics, BioTools & Diagnostics, and Synthetic Biology — but the unifying thesis is platform science. In therapeutics, it has backed mental health (Delix, Compass), women's health (Freya), and cell/gene therapy delivery (Replay). Its tools and synthetic biology holdings span CRISPR diagnostics (VedaBio), proteomics (Glyphic), genome writing (Inscripta, Constructive Bio), and metabolomics (Matterworks).

Who leads the investment team at OMX Ventures?

OMX does not publicly name its managing partners, investment committee members, or senior investment professionals on its website or in available public filings. The firm's principals remain undisclosed in the sources consulted.

What is OMX's investment stage and check-size range?

Altss research tags OMX as targeting Early Stage, Seed, and Start-up, but the firm does not publish a minimum or maximum check size. Without a disclosed fund size or deployment figure, specific commitment bands cannot be verified.

Does OMX invest only in the US, or does it actively deploy in Europe?

The firm positions itself explicitly as operating on both sides of the Atlantic. Portfolio companies include US-domiciled entities as well as UK-headquartered firms such as Constructive Bio, reflecting a geographic mandate that spans North America and Europe.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on venture capital firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Lincolnshire Venture Capital profiles